financetom
Business
financetom
/
Business
/
Silvercorp Metals Provides Updated Resource Estimate for Condor Project in Ecuador
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Silvercorp Metals Provides Updated Resource Estimate for Condor Project in Ecuador
May 26, 2025 5:49 AM

08:40 AM EDT, 05/12/2025 (MT Newswires) -- Silvercorp (SVM.TO) reported Monday an updated National Instrument 43-101 resource estimate for the Condor gold project in Ecuador.

The study outlined total indicated underground resources of 3.17 million tonnes at the Camp and Los Cuyes deposits, containing 370,000 ounces of gold equivalent at a cutoff grade of 2.2 grams per tonne gold equivalent.

Total inferred underground resources stood at 12.1 million tonnes containing 1.50 million ounces of gold equivalent at the same cutoff grade.

The company said favorable initial metallurgical test work indicates laboratory-based gold recoveries of up to 96% at Camp and 88% at Los Cuyes based on cyanide leaching.

Silvercorp said it will launch a 3,500-meter surface drilling program at Los Cuyes and Camp in May to test several areas.

The company plans to publish a preliminary economic assessment by the end of 2025 for an underground operation.

Silvercorp's share price rose 6.3% on Friday to $5.38 on the TSX.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Applied Therapeutics' Govorestat Faces 'Significant' Uncertainty in Galactosemia Treatment After FDA Rejection, RBC Says
Applied Therapeutics' Govorestat Faces 'Significant' Uncertainty in Galactosemia Treatment After FDA Rejection, RBC Says
Nov 29, 2024
12:15 PM EST, 11/29/2024 (MT Newswires) -- Applied Therapeutics' ( APLT ) lead drug candidate, govorestat, likely faces significant uncertainty in potentially treating galactosemia after the US Food and Drug Administration rejected the biopharmaceutical company's drug application, RBC Capital Markets said Friday. Late Wednesday, the clinical-stage company said the FDA is unable to approve govorestat's new drug application for the...
Market Chatter: Grifols in Talks With Banks to Extend Credit Facility, Refinance Bonds
Market Chatter: Grifols in Talks With Banks to Extend Credit Facility, Refinance Bonds
Nov 29, 2024
12:17 PM EST, 11/29/2024 (MT Newswires) -- Grifols ( GRFS ) is in discussions with banks to extend a $1 billion revolving credit facility and refinance 370 million euros ($390.3 million) in bonds due 2025, Bloomberg News reported Thursday, citing an interview with Chief Executive Officer Nacho Abia. Several banks have already confirmed interest in refinancing, even expanding the facility,...
EU regulators scrap merger power aimed at killer acquisitions after court veto
EU regulators scrap merger power aimed at killer acquisitions after court veto
Nov 29, 2024
BRUSSELS, Nov 29 (Reuters) - EU antitrust regulators on Friday ditched a merger tool aimed at killer acquisitions two months after Europe's top court vetoed this expanded merger power which had been widely criticised by companies as regulatory over-reach. The Luxembourg-based Court of Justice in September sided with Illumina ( ILMN ) in its fight against the European Commission's decision...
EU regulators scrap merger power aimed at killer acquisitions after court veto
EU regulators scrap merger power aimed at killer acquisitions after court veto
Nov 29, 2024
BRUSSELS (Reuters) - EU antitrust regulators on Friday ditched a merger tool aimed at killer acquisitions two months after Europe's top court vetoed this expanded merger power which had been widely criticised by companies as regulatory over-reach. The Luxembourg-based Court of Justice in September sided with Illumina ( ILMN ) in its fight against the European Commission's decision to wield...
Copyright 2023-2026 - www.financetom.com All Rights Reserved